Ameritas Advisory Services’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-136
Closed -$7.79K 1409
2025
Q3
$7.79K Sell
136
-115
-46% -$6.62K ﹤0.01% 1734
2025
Q2
$14.8K Buy
+251
New +$16.2K ﹤0.01% 1859
2023
Q2
Sell
-623
Closed -$36.1K 1350
2023
Q1
$36.1K Buy
+623
New +$39.9K ﹤0.01% 1388

Other funds holding GMED

Ameritas Advisory Services's GMED Position: Q4 2025 in Review

Ameritas Advisory Services sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 136 shares — an estimated $7.79K sold.

Ameritas Advisory Services first reported a position in GMED in Q1 2023 and held it in 3 quarters. The position peaked at $36.1K in Q1 2023. 563 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

  • Ameritas Advisory Services reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
  • Ameritas Advisory Services sold 136 Globus Medical shares in Q4 2025, an estimated $7.79K.
  • Ameritas Advisory Services first reported a position in Globus Medical in Q1 2023 and held it in 3 quarters.
  • Ameritas Advisory Services's Globus Medical position peaked at $36.1K in Q1 2023.
  • 563 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on Ameritas Advisory Services's 13F filing for Q4 2025, filed 4 Feb 2026.